Jushi Holdings (JUSHF) Assets Average (2022 - 2026)
Jushi Holdings (JUSHF) posted quarterly Assets Average of $432.5 million for Q2 2026, little changed year-over-year from $433.0 million in Q2 2025, and up 0.87% quarter-over-quarter from $428.7 million in Q1 2026.
Jushi Holdings (JUSHF) Assets Average (2022 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Assets Average for 5 consecutive years, with $432.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets Average changed 0.12% year-over-year to $432.5 million; the TTM figure through Jun 2026 stood at $432.5 million (changed 0.12% YoY), while the FY2025 annual figure was $431.3 million, down 4.54% from the prior year.
- Assets Average advanced to $432.5 million in Q2 2026 per JUSHF's latest filing, from $428.7 million in the prior quarter.
- Across five years, Assets Average topped out at $688.1 million in Q3 2022 and bottomed at $427.0 million in Q4 2025.
- Historically, Assets Average has averaged $501.7 million across 5 years, with a median of $458.6 million in 2024.
- Annual changes were most pronounced in 2023 — Assets Average retreated 28.05% — and 2026, when it fell 0.12%.
- Jushi Holdings' Assets Average stood at $597.4 million in 2022, then retreated by 20.31% to $476.0 million in 2023, then dropped by 7.29% to $441.3 million in 2024, then fell by 3.24% to $427.0 million in 2025, then gained by 1.28% to $432.5 million in 2026.
- Business Quant data shows JUSHF's Assets Average at $432.5 million in Q2 2026, $428.7 million in Q1 2026, and $427.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 432.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 432.47 Mn |
| Mar 31, 2026 | 428.74 Mn |
| Dec 31, 2025 | 427.02 Mn |
| Sep 30, 2025 | 432.03 Mn |
| Jun 30, 2025 | 432.99 Mn |
| Mar 31, 2025 | 436.97 Mn |
| Dec 31, 2024 | 441.32 Mn |
| Sep 30, 2024 | 448.78 Mn |
| Jun 30, 2024 | 456.54 Mn |
| Mar 31, 2024 | 460.62 Mn |
| Dec 31, 2023 | 476.03 Mn |
| Sep 30, 2023 | 495.08 Mn |
| Jun 30, 2023 | 510.76 Mn |
| Mar 31, 2023 | 524.69 Mn |
| Dec 31, 2022 | 597.38 Mn |
| Sep 30, 2022 | 688.09 Mn |
| Jun 30, 2022 | 685.16 Mn |
| Mar 31, 2022 | 655.80 Mn |